G. Crowther

发表

An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile Infection.

M. Wilcox, C. Chilton, G. Crowther, 2016, Methods in molecular biology.

Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection

M. Wilcox, T. Monaghan, M. Brindell, 2016, The Journal of antimicrobial chemotherapy.

Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.

M. Wilcox, J. Freeman, S. Nicholson, 2015, The Journal of antimicrobial chemotherapy.

In vitro activity of cadazolid against clinically relevant Clostridium difficile isolates and in an in vitro gut model of C. difficile infection.

M. Wilcox, J. Freeman, C. Chilton, 2014, The Journal of antimicrobial chemotherapy.

Efficacy of surotomycin in an in vitro gut model of Clostridium difficile infection.

M. Wilcox, J. Freeman, S. Nicholson, 2014, The Journal of antimicrobial chemotherapy.

Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.

M. Wilcox, J. Freeman, S. Nicholson, 2014, The Journal of antimicrobial chemotherapy.

Evaluation of antimicrobial activity of ceftaroline against Clostridium difficile and propensity to induce C. difficile infection in an in vitro human gut model.

M. Wilcox, J. Freeman, C. Chilton, 2013, The Journal of antimicrobial chemotherapy.

Mixed infection by Clostridium difficile in an in vitro model of the human gut.

M. Wilcox, W. Fawley, J. Freeman, 2013, The Journal of antimicrobial chemotherapy.

Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.

J. de Gunzburg, M. Wilcox, A. Andremont, 2020, The Journal of antimicrobial chemotherapy.

Effectiveness of titanium nitride silver coatings against Staphylococcus spp. in the presence of BSA and whole blood conditioning agents

C. Banks, K. Whitehead, P. Kelly, 2019, International Biodeterioration & Biodegradation.

Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production

M. Wilcox, C. Chilton, H. Ashwin, 2016, PloS one.

Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut model.

M. Wilcox, J. Freeman, S. Nicholson, 2012, The Journal of antimicrobial chemotherapy.

Evaluation of the effect of oritavancin on Clostridium difficile spore germination, outgrowth and recovery.

M. Wilcox, J. Freeman, S. Nicholson, 2013, The Journal of antimicrobial chemotherapy.

In vitro susceptibility of Clostridium difficile to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against C. difficile

M. Wilcox, P. Warn, J. Freeman, 2015, The Journal of antimicrobial chemotherapy.

Efficacy of Topical Vancomycin- and Gentamicin-Loaded Calcium Sulfate Beads or Systemic Antibiotics in Eradicating Polymicrobial Biofilms Isolated from Diabetic Foot Infections within an In Vitro Wound Model

A. Noel, G. Crowther, M. Bayliss, 2021, Antimicrobial Agents and Chemotherapy.

M. Bayliss, N. Callaghan, G. Crowther, 2021 .

Development and characterisation of an in vitro human gut model to study the biofilm mode of growth of Clostridium difficile and the indigenous gut microbiota

G. Crowther, 2013 .

Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis

S. MacNeil, P. Monk, Esther Karunakaran, 2020, Cells.

Graphene Matrices as Carriers for Metal Ions against Antibiotic Susceptible and Resistant Bacterial Pathogens

C. Banks, K. Whitehead, A. McBain, 2021, Coatings.

Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.

M. Wilcox, J. Freeman, C. Chilton, 2013, The Journal of antimicrobial chemotherapy.

Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm

M. Wilcox, G. Crowther, 2015, Infection and drug resistance.

Infection and Drug Resistance Dovepress

M. Wilcox, G. Crowther, 2022 .

Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota

M. Wilcox, J. Freeman, S. Nicholson, 2014, PloS one.

Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model.

M. Wilcox, A. Karas, C. Chilton, 2015, The Journal of antimicrobial chemotherapy.

Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.

M. Wilcox, A. Karas, D. Ewin, 2016, The Journal of antimicrobial chemotherapy.

Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model.

M. Wilcox, J. Freeman, S. Nicholson, 2014, The Journal of antimicrobial chemotherapy.

SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model

M. Wilcox, J. Freeman, R. Vickers, 2014, The Journal of antimicrobial chemotherapy.

Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.

M. Wilcox, W. Fawley, J. Freeman, 2012, The Journal of antimicrobial chemotherapy.

Effectiveness of a short (4 day) course of oritavancin in the treatment of simulated Clostridium difficile infection using a human gut model.

M. Wilcox, J. Freeman, C. Chilton, 2012, The Journal of antimicrobial chemotherapy.

Antibiotic therapy and Clostridium difficile infection – primum non nocere – first do no harm

M. Wilcox, G. Crowther, 2015 .

Co-amoxiclav induces proliferation and cytotoxin production of Clostridium difficile ribotype 027 in a human gut model.

M. Wilcox, J. Freeman, S. Nicholson, 2012, The Journal of antimicrobial chemotherapy.

An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile Infection.

M. Wilcox, C. Chilton, G. Crowther, 2016, Methods in molecular biology.

Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated Clostridium difficile infection in an in vitro human gut model.

A. Karas, C. Chilton, G. Crowther, 2015, The Journal of antimicrobial chemotherapy.